Dimitrios Moustakas, DPM
Podiatrist · Smyrna, DENPI 1982131173
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 54.1% of the total. Reporting peaked in 2021 at $2,413 and has fallen 63.9% since, to $871 in 2025.
Across 75 payments — averaging $89.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$4K
- Smith+Nephew$2K
- Organogenesis Inc.$228
- Next Science LLC$174
- Linvatec Corporation$103
- Boston Scientific$99
- plus $279 from 12 others
What the payments were for
- Food & beverage$3,08846%
- Education$3,60054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 4 | $3,620 |
| Smith+Nephew | 50 | $2,185 |
| Organogenesis Inc. | 4 | $228 |
| Next Science LLC | 2 | $174 |
| Linvatec Corporation | 1 | $103 |
| Boston Scientific | 1 | $99 |
| Biocomposites Inc | 1 | $47 |
| Reapplix Inc. | 2 | $44 |
| Medtronic | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Kerecis Limited | 1 | $21 |
| Abbott | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Hydrofera LLC | 1 | $19 |
| KCI USA, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
| Bioventus LLC | 1 | $16 |
| Paragon 28, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$491
- Stravix$275
- Xperience$144
- BlastX$144
- SurgX$144
- PURAPLY WOUND MATRIX$143
- Affinity$143
- Apligraf$143
- Grafix$138
- Grafix XC$125
- STRAVIX PL$125
- PICO 14$107
- BioBrace 23mm$103
- NeoSpan$103
- ALLOGRAFT TISSUE$103
How this compares
$6,688 in reported general payments places this provider in the 80th percentile of 37 podiatrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 25 | $1,149 |
| Mupirocin | 18 | $122 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $118 |
| Meloxicam | 18 | $85 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Smyrna
- Linda LawtonSmyrna$37
- Jennifer SeifertNewark$12K
- Harold GruberWilmington$10K
- Lahari MadulapallyWilmington$9K
- Jason KlineNewark$9K
- Matthew WaxmanMiddletown$7K
- Brian McDermottWilmington$7K
- James BrayNewark$7K
- Joseph WendolowskiLewes$5K
- Alexis LundHockessin$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.